Cullinan Therapeutics, Inc. (CGEM) revenue

Revenue · fiscal 2021
$18.94M

Only 1 fiscal year of revenue is on record here for Cullinan Therapeutics, Inc. (CGEM); a history needs at least 3. Figures as of 18 Nov 2026, 12:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2021
$18.94M
Fiscal years on record
12021–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; one is on record here for Cullinan Therapeutics, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Cullinan Therapeutics, Inc. revenue, year by year

Cullinan Therapeutics, Inc. (CGEM) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2021$18.94M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on CGEM

Cullinan Therapeutics, Inc., figure by figure

Cullinan Therapeutics, Inc. (CGEM) overview: price, valuation and scorecard

Cullinan Therapeutics, Inc. revenue: questions and answers

How is Cullinan Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cullinan Therapeutics, Inc. (CGEM) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CGEM/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.